Depression Status Is Associated with Functional Decline Over 1-Year Following Acute Stroke.

Journal Article (Journal Article;Multicenter Study)

BACKGROUND: We investigated the independent association of depression status at 3 and 12 months after stroke and functional decline. METHODS: Data were obtained as part of the multicenter Adherence eValuation After Ischemic stroke Longitudinal (AVAIL) registry. Depression was assessed with the Patient Health Questionnaire-8 (depression, PHQ-8 ≥ 10), and functional status was assessed with the modified Rankin score (mRS) at 3 and 12 months following hospitalization for ischemic stroke. We used logistic regression analyses to evaluate the independent association between the change in depression rating and the change in mRS. RESULTS: Among 1444 patients, 75% did not have depression at either time point, 9.2% had persistent depression, 8.7% had resolving depression, and 7% had incident depression at 12 months. After covariate adjustment, depression status at 3 and 12 months remained associated with worsening mRS (P = .01). Compared with patients without depression, those with resolving depression were less likely to have a worsening mRS (odds ratio [OR] = .49, 95% confidence interval [CI]: .29-0.83). There was no difference in functional decline between those with no depression and those with persistent depression; however, those with persistent depression had worse mRS at both time points (median mRS: 2.5 [Q1-Q3: 2-3] at 3 months; 2 [2-3] at 12 months) than those with no depression (mRS: 1 [0-2] at both 3 and 12 months), P < .0001. CONCLUSIONS: Patients with resolving depression in the first year after stroke were less likely to have functional deterioration than those without depression. Greater functional impairment was present in the setting of depression.

Full Text

Duke Authors

Cited Authors

  • El Husseini, N; Goldstein, LB; Peterson, ED; Zhao, X; Olson, DM; Williams, JW; Bushnell, C; Laskowitz, DT

Published Date

  • July 2017

Published In

Volume / Issue

  • 26 / 7

Start / End Page

  • 1393 - 1399

PubMed ID

  • 28389192

Pubmed Central ID

  • 28389192

Electronic International Standard Serial Number (EISSN)

  • 1532-8511

Digital Object Identifier (DOI)

  • 10.1016/j.jstrokecerebrovasdis.2017.03.026


  • eng

Conference Location

  • United States